E-LIB Suche - Ergebnisse für: Israel, Elliot

1

Trial Characteristics of Randomized Controlled Trials Evalu..:

Ologundudu, Leonardo ; Islam, Nazmul ; Rayner, Daniel...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB175 , 2024

Link: https://doi.org/10.1016/..

2

Trial Characteristics of Randomized Controlled Trials Evalu..:

Wong, Melanie ; Ologundudu, Leonardo ; Islam, Nazmul...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB94 , 2024

Link: https://doi.org/10.1016/..

3

Protein–Protein interactive networks identified in bronchoa..:

Hastie, Annette T. ; Bishop, Andrew C. ; Khan, Mohammad S....
Clinical & Experimental Allergy. 54 (2024) 4 - p. 265-277 , 2024

Link: https://doi.org/10.1111/..

4

Patient Experiences When Managing Acute Exacerbation of Ast..:

Gardner, Donna ; Castro, Mario ; Israel, Elliot...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB21 , 2024

Link: https://doi.org/10.1016/..

5

Efficacy of albuterol–budesonide asthma rescue inhaler in a..:

Israel, Elliot ; Chipps, Bradley ; Beasley, Richard...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB98 , 2024

Link: https://doi.org/10.1016/..

6

Utility of eosinophil peroxidase as a biomarker of eosinoph..:

Tang, Monica ; Charbit, Annabelle R. ; Johansson, Mats W....
Journal of Allergy and Clinical Immunology. , 2024

Link: https://doi.org/10.1016/..

7

Phenotyping of Severe Asthma in the Era of Broad-Acting Ant..:

Bourdin, Arnaud ; Brusselle, Guy ; Couillard, Simon...
The Journal of Allergy and Clinical Immunology: In Practice. 12 (2024) 4 - p. 809-823 , 2024

Link: https://doi.org/10.1016/..

8

Efficacy of tezepelumab in patients with severe asthma and ..:

Israel, Elliot ; Castro, Mario ; Ambrose, Christopher S....
ERJ Open Research. , 2024

Link: https://doi.org/10.1183/..

9

An AAAAI/ACAAI Joint Task Force on Practice Parameters Upda..:

Maxemous, Karl ; Bakshi, Devyani ; Chu, Derek...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB100 , 2024

Link: https://doi.org/10.1016/..

10

Biomarkers and clinical outcomes after tezepelumab cessatio:

Brightling, Christopher E. ; Caminati, Marco ; Llanos, Jean-Pierre...
Annals of Allergy, Asthma & Immunology. , 2024

Link: https://doi.org/10.1016/..

11

Albuterol–budesonide rescue reduces progression from asthma..:

Chipps, Bradley E. ; Papi, Alberto ; Beasley, Richard...
The Journal of Allergy and Clinical Immunology: In Practice. , 2024

Link: https://doi.org/10.1016/..

12

Peroxidase-mediated mucin cross-linking drives pathologic m..:

Liegeois, Maude A. ; Braunreuther, Margaret ; Charbit, Annabelle R....
JCI Insight. , 2024

Link: https://doi.org/10.1172/..

13

Albuterol–budesonide fixed-dose combination rescue inhaler ..:

Papi, Alberto ; Chipps, Bradley E. ; Beasley, Richard...
Therapeutic Advances in Respiratory Disease. 18 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

14

Asthma morbidity measures across Black ethnic subgroups:

Ishmael, Leah ; Apter, Andrea ; Busse, Paula J....
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. 408-417 , 2024

Link: https://doi.org/10.1016/..

15

CCL5 is a Potential Bridge Between Type 1 and Type 2 Inflam..:

Gauthier, Marc ; Kale, Sagar ; Oriss, Timothy...
Journal of Allergy and Clinical Immunology. 151 (2023) 2 - p. AB224 , 2023

Link: https://doi.org/10.1016/..